Get 20% lifetime commission for referring investors to digrin.com
here.
Aadi Bioscience, Inc. (AADI) Financials
Stock symbol AADI is outdated, potentially delisted? Maybe it is available on other exchange?
AADI Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2024 | 70.3 million | 17.8 million |
| Sept. 30, 2024 | 85.7 million | 16.8 million |
| June 30, 2024 | 101.6 million | 22.8 million |
| March 31, 2024 | 111.1 million | 20.6 million |
AADI Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2024 | ? | ? |
| Sept. 30, 2024 | -20.5 million | 9.1 million |
| June 30, 2024 | -9.7 million | 2.8 million |
| March 31, 2024 | -20.4 million | 3.6 million |
AADI Net Income
No data available :(
AADI Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2024 | 47.2 million | 565000 | 833000 |
| Sept. 30, 2024 | 62.6 million | 624000 | 946000 |
| June 30, 2024 | 78.6 million | 682000 | 1.1 million |
| March 31, 2024 | 88.3 million | 738000 | 1.2 million |
AADI Shares Outstanding
AADI Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2024 | - | 14.3 million | 11.1 million | - |
| Sept. 30, 2024 | 2.3 million | 10.0 million | 7.2 million | - |
| June 30, 2024 | 541000 | 13.1 million | 7.9 million | - |
| March 31, 2024 | 739000 | 13.6 million | 10.6 million | - |
AADI Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2024 | 7.2 million | 790000 |
| Sept. 30, 2024 | 7.2 million | 804000 |
| June 30, 2024 | 6.2 million | 778000 |
| March 31, 2024 | 5.4 million | 652000 |
AADI Revenue by Segment
Graph available only for paid members. Upgrade to see it.
AADI
Price: $2.05
52 week price:
Earnings Per Share: -2.36 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 52100
Market Capitalization: 94.9 million